New hope for stomach cancer that has spread
NCT ID NCT07384234
Summary
This study is testing whether adding a new immunotherapy drug (SHR-1701) to standard chemotherapy works better for advanced stomach cancer that has spread to the abdominal lining. Researchers will compare two different drug combinations in 60 patients who haven't had prior cancer treatment. The main goal is to see if this approach helps patients live longer and potentially makes surgery an option for more people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, China
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.